Image Credit: Canva
Katie Donnell, a 28-year-old teacher from Florida, was the epitome of health- followed a rigorous fitness routine, ate only organic foods, and had no diagnosed medical conditions. But in August 2021, her life was suddenly cut short by a heart attack. Her grieving mother, Lori Barranon, now blames one daily habit which is rather an unsuspected factor that may have contributed to her daughter's premature death—too much caffeine.".
In spite of her devotion to a fit lifestyle, Donnell drank several energy drinks per day, along with coffee and pre-workout caffeine supplements. Although medical doctors did not link her death directly to caffeine, Barranon is certain that her daughter's dependency on these drinks had deadly results.
Donnell was hanging out with friends when she simply collapsed, her eyes rolling back in her head as she lost consciousness. At first, people assumed she was having a stroke. Emergency workers came in and tried to bring her back around, but it was too late. She had not received oxygen for too long a period of time and suffered from massive brain damage. After three hours of medical treatment, she never did come around.
Physicians put Donnell into a medically induced coma in hopes of stabilizing her situation, but she had worsening seizures during the ensuing days. Following ten days of life support, her family was forced to make the sad decision to release her.
Though caffeine is common in increasing alertness and energizing, it has fatal results when used in excess. The medical fraternity advises that excessive caffeine can elevate blood pressure, boost heart rate, and lead to cardiovascular problems. Caffeine's ability to acutely elevate blood pressure can strain the cardiovascular system, enhancing the possibility of heart arrhythmias and cardiac arrest, warns the National Library of Medicine.
The Mayo Clinic says that a daily intake of up to 400 milligrams of caffeine is generally safe for adults. This would be the equivalent of about four small cups of coffee, five or six shots of espresso, or two to four large store-bought coffee drinks. Energy drinks, though, contain between 100 and 300 milligrams of caffeine per can, so having multiple energy drinks a day in addition to coffee or supplements is an easy way to exceed the safe amount.
In Donnell's case, the amount of caffeine that she consumed daily was shocking. Barranon subsequently found that her daughter would buy four-packs of energy beverages twice or three times a week, aside from consuming massive quantities of coffee. Her vehicle had several packs of empty energy drink cans, indicating a reliance on these products.
Donnell's case is not the only one. In 2018, 21-year-old Australian musician Lachlan Foote passed away due to caffeine overdose after he added caffeine powder to his protein shake. Recently, in 2023, a 20-year-old Jazmin Garza was put on life support after drinking only a few sips of an energy drink before exercising, according to GoFundMe page. These events underscore the possible risks of excessive consumption, particularly among youth who are not yet fully cognizant of the risks.
While moderate use of caffeine can be beneficial in terms of enhanced concentration and enhanced physical performance, excessive use can cause severe health complications. Side effects include heightened heart rate, elevated blood pressure, anxiety, and, in extreme instances, heart attacks or sudden cardiac arrest.
Barranon is now on a crusade to inform others of the secret dangers of energy drinks and caffeine supplements. She implores parents to keep their children's intake in check, cautioning that too much caffeine can have catastrophic effects.
If you don't keep your children away from this stuff, you might be in my position where your life is destroyed," she said. "It's so dangerous and lethal. This is affecting my entire family.
Barranon now goes out of her way to warn others whenever she notices a person with an energy drink in their hand. "I beg people to advise their children and observe what they're doing. I was watching Katie, but I had no idea of the extent of it."
Caffeine intoxication, or caffeine overdose or toxicity, is the condition that results from excessive caffeine intake and leads to adverse effects on the body. Although caffeine is commonly ingested in the form of coffee, tea, soda, and energy drinks, excessive intake has the potential to result in serious health hazards.
The majority of Americans ingest caffeine every day, with moderate use having positive effects such as heightened alertness and energy. But when the amount of caffeine is beyond what the human body can metabolize, it can lead to symptoms that vary from mild pain to severe medical issues.
As stated by the U.S. Food and Drug Administration (FDA), adults can safely consume 400 milligrams of caffeine daily—about the equivalent of two to three 12-ounce cups of coffee. Caffeine sensitivity, however, differs among individuals, and medical conditions and medications can enhance sensitivity.
For kids, the dangers are even greater. Although there is no official safe amount for children, experts warn strongly against the use of caffeine in children younger than 2 years and urge children and teens to steer clear of energy drinks entirely.
The widespread distribution of high-caffeine energy beverages has created increasing concerns among health practitioners. In many nations, there are controls on the sale of energy drinks to minors, but caffeine-related health issues are extensively under-discussed.
Public health experts point out the importance of clearer labelling on energy drinks, outlining their levels of caffeine and associated risks. Some are calling for stricter regulations, such as age limits and warnings regarding the perils of overuse of caffeine.
For those who rely on caffeine to make it through the day, professionals advise replacing it with safer sources, like herbal teas or natural energy sources such as balanced nutrition and adequate hydration. Fitness buffs, in particular, need to exercise caution when using pre-workout supplements that have excessive amounts of caffeine and other stimulants.
Katie Donnell's sad tale is a harsh reminder that even seemingly innocuous habits can have life-changing repercussions. Although caffeine is a ubiquitous and socially tolerated stimulant, overconsumption—particularly when combined with intense exercise—can place extreme stress on the heart.
While energy drinks are more popular than ever, it is essential that everyone, parents in particular, as well as policymakers, take a closer examination at their possible effects on health. Through increased awareness and education for responsible use, such tragedies as Donnell's can be avoided in the future.
For the time being, Barranon continues to tell her daughter's story hoping that it will be a warning to others. "I don't want anyone else to experience this suffering. If I can save even one life, then Katie's story won't be for nothing."
(Credit-Canva)
Cancer is an umbrella term for abnormal excess growth that can occur in any part of the body. Leukemia is the cancer of blood, which means there is rapid growth of abnormal blood cells. This growth starts in the bone marrow, which is where your body makes blood. The Cleveland Clinic explains that unlike other cancers, leukemia does not form a mass or tumor that can be detected in a CT scan.
The usual treatment of Leukemia involves Chemotherapy, whether by pill, injection into your vein or a shot under your skin. Another treatment for it is immunotherapy which uses a drug to boost your body’ defense system so that it can fight the cancer itself. Now, a research by American Association for Cancer Research April 2025, has revealed that a pre-made version of immunotherapy can effectively fight blood cancers. This "off-the-shelf" approach offers a potentially faster and easier way to deliver this powerful therapy to patients in need.
This new way to treat blood cancer uses special immune cells called natural killer cells, or NK cells. These NK cells have been changed in a lab to have special tools, called CARs, that help them find and kill cancer cells. What's really helpful is that these CAR NK cells can be made ahead of time from healthy people and stored. This means doctors can just take them off the shelf and give them to patients who need them quickly, without having to wait for a treatment to be made just for them, making the whole process much simpler and faster.
The results from using this ready-made CAR NK cell treatment yielded promising results, especially for people with a type of blood cancer called acute myeloid leukemia, or AML. The scientists found that after getting this treatment, some of the patients with AML had their cancer completely disappear. This is called complete remission, and it means there were no signs of cancer left in their blood. These early successes give a lot of hope for a new and better way to treat this difficult disease.
Notably, AML is a very fast-growing and serious cancer. According to American Cancer Society this cancer develops in the myeloid cell, the cells that would normally become white blood cells. This type of cancer develops quickly, hence needs to be treated with the same urgency.
The first group of patients who received this ready-made CAR NK cell treatment were people whose leukemia had either stopped responding to other treatments or had come back after treatment. These are often the most difficult cases to treat. The fact that some of these patients had such a good response to the SENTI-202 treatment, which is a safety feature to the SENTI-202 cells. It's like a special switch that stops the NK cells from attacking healthy cells in the body. With their cancer completely disappearing, is a very encouraging sign that this new approach could offer hope to patients who have run out of other options.
The researchers are hopeful about the new treatment and early success for the treatment. They believe that this ready-made approach could lead to new types of immune therapies that are much easier to produce and give to patients. Researchers emphasized that there's a big need for better treatments for AML, and he hopes this new method can become an important option for these patients who often have very limited choices.
It's important to remember that these are just the first results from an ongoing study. The scientists are still enrolling more patients to learn even more about how safe and how well SENTI-202 works. They need to keep studying it to make sure it's a reliable and effective treatment for more people with blood cancers. Before this treatment can be used widely, the findings need to be carefully reviewed and published in a scientific journal.
Credits: Canva
The uncertainty around the Novavax's COVID-19 vaccine has been exacerbated by the Trump administration. The new government has imposed new requirements on the nation's only traditional protein-based vaccine. These new requirements have led to many confusions about vaccine updates, including other vaccines too, which await approval.
Novavax is the maker of the protein-based COVID-19 vaccine, which was on track to receive full approval from the US Food and Drug Administration (FDA) by April 1. However, the approval process was paused because of Dr Sara Brenner, the FDA's acting commissioner. The reason for delay has raised many questions about the interference, including political, especially after Dr Peter Marks, FDA's longtime vaccine chief had left following disagreements with Health Secretary Robert F Kennedy Jr. These events have further led to the apprehensions of uncertainty regarding the vaccine's future.
As of now, Novavax's vaccine is only authorized for emergency use. Unlike mRNA vaccines form Pfizer and Moderna, which have full approval, the Novavax vaccine holds the EUA or the Emergency Use Authorization, which allows it to be distributed during public health emergencies. However, once the emergency ends, the FDA can remove these vaccines from market unless full approval is granted.
The FDA had initially planned to approve Novavax's vaccine by its April 1 target date. However, sources familiar with the situation revealed that Trump appointees influenced the delay. Since then, Novavax has been in discussions with the FDA to determine additional requirements for approval. In the meantime, the FDA's recent comments have fueled concerns that Novavax’s vaccine may be treated as a “new product” due to its updates to match last year’s coronavirus strain. This would require new clinical trials, a process unlikely to be completed before the fall.
ALSO READ: Novavax Says FDA Approval Back on Track for Its COVID Vaccine
This approach to Novavax’s vaccine approval stands in stark contrast to the FDA’s treatment of the mRNA vaccines, where annual strain updates have been handled in a way similar to flu vaccines, requiring only small-scale tests to demonstrate the vaccine’s continued effectiveness against new strains. Dr. Paul Offit, a vaccine expert, argued that it would be unnecessary to treat these annual updates as “new products” requiring full trials, as long as the updated vaccines show that they produce protective antibody levels.
Of course Robert F Kennedy Jr will have a role to play, being the Health Secretary, and a known vaccine skeptic. Despite claiming in recent speeches that he is not anti-vaccine, Kennedy’s past associations with anti-vaccine groups have raised alarms. His nonprofit, Children’s Health Defense, has been involved in campaigns questioning vaccine safety, and Kennedy himself has made public statements suggesting that vaccines can cause autism—a long-debunked claim.
His actions have also contributed to the uncertainty that surrounds the Novavax's approval today and the overall direction of US vaccine policies.
What sets Novavax apart from other COVID-19 vaccines is its traditional approach. While Pfizer and Moderna’s mRNA vaccines use genetic instructions to create a temporary version of the virus’ spike protein, Novavax’s vaccine contains lab-grown copies of the spike protein itself. This approach has been used for decades in vaccines for diseases like hepatitis B and shingles, making it a more familiar method for people who may be hesitant about mRNA vaccines.
Credit: Canva
Danish multinational pharmaceutical company Novo Nordisk has launched Wegovy in Thailand, marking the entry of its hugely popular weight loss drug in Southeast Asian market. First launched in 2021, Wegovy helped make Novo Nordisk Europe's most valuable listed company until recently, worth $615 billion at its peak. Wegovy is a semaglutide shot, which means that it is a GLP-1 receptor agonist.
"We actually received the Thai FDA approval already in 2023," said Enrico Canal Bruland, vice president and general manager of Novo's Thai subsidiary. He noted that Novo was making Wegovy available in Thailand ahead of rival Eli Lilly's Zepbound. Wegovy is currently available for prescription in private hospitals around the country and will be available soon in public hospitals. Notably, Bruland declined to provide details on Wegovy's pricing in Thailand, which has a population of around 66 million, or Novo Nordisk's plans for expansion into other Southeast Asian markets.
Notably, the most popular GLP-1 agonist Ozempic was also created by Novo Nordisk. Earlier this month, the pharma giant expanded its research in the field diabetes and weight loss drug and announced that its diabetes pill, Rybelsus, demonstrated cardiovascular benefits in a late-stage trial. The findings pave the way for the medication to become a new treatment option for people living with both diabetes and heart disease.
How Do Semaglutides Work?
Semglutide is the synthetic version of GLP-1—a natural hormone produced in the intestines that regulates blood sugar, appetite, and digestion. Now, every time you eat, your body produces various hormones, including GLP-1. These are called Post nutrition hormones, and help you absorb the energy you just consumed.
GLP-1 travels to your pancreas, prompting it to produce insulin. It also travels to the hypothalamus in your brain, which gives you the feeling of being full or satiated. Ozempic imitates this hormone, thereby, silencing the food chatter in the brain. Interestingly, for some people this food chatter is really quiet ( people with low appetite) and for others it is an outbrurst, (people who generally binge eat.) So with Ozempic, silencing this self-talk in the brain, people tend to lose their appetite and eventually weight.
However, it is important to note that losing weight includes not just fat but muscle as well. Losing too much muscle can lead to reduced strength and a shorter life span. Notably, records show that most people who start taking them stop it at 12 weeks; therefore, it is important for some but not for others.
Notably, last month, US pharma major Eli Lilly launched the obesity management drug Mounjaro in India at one-fifth of the US price. The company rolled out the drug in a single-dose vial following the marketing authorisation from the Central Drugs Standard Control Organization (CDSCO). It has been priced at Rs 3,500 for a 2.5 mg vial and Rs 4,375 for a 5 mg vial. "It is a first-of-its-kind treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors," the company said.
© 2024 Bennett, Coleman & Company Limited